Understanding cardiac output

Critical Care

Volumn 12, Issue 4, 2008, Pages

  Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; ENOXIMONE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LEVOSIMENDAN; MILRINONE; NORADRENALIN; PHENYLEPHRINE; VASODILATOR AGENT;

ADVERSE OUTCOME; ARTICLE; BICYCLE ERGOMETRY; BLOOD VESSEL TONE; CARDIOGENIC SHOCK; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EXERCISE INTENSITY; FLUID THERAPY; HEART AFTERLOAD; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART OUTPUT MEASUREMENT; HEART PRELOAD; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE TACHYCARDIA; HUMAN; MORTALITY; MUSCLE STRETCHING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS; STARLING LAW; SUPRAVENTRICULAR TACHYCARDIA; ANIMAL; EDITORIAL; PHYSIOLOGY; PRACTICE GUIDELINE;

ANIMALS; CARDIAC OUTPUT; HEART RATE; HUMANS; MYOCARDIAL CONTRACTION; PRACTICE GUIDELINES AS TOPIC; STROKE VOLUME;

EID: 65849388666     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6975     Document Type: Article

References (13)

1. Suffredini AF Fromm RE Parker MM Brenner M Kovacs JA Wesley RA Parrillo JE The cardiovascular response of normal humans to the administration of endotoxin N Engl J Med 1989, 321:280-287 2664516
2. 2+i and cell contraction in cultured chick ventricular myocytes Circ Res 1994, 75:285-295 7518362
3. The Xamoterol in Severe Heart Failure Study Group Xamoterol in severe heart failure Lancet 1990, 336:1-6 10.1016/0140-6736(90)91517-E 1694945
4. Packer M Carver JR Rodehoffer RJ Ivanhoe RJ DiBianco R Zeldis SM Hendrix GH Bommer WJ Elkayam U Kukin ML Mallis GI Sollano JA Shannon J Tandon PK Demets DL Effect of oral milrinone on mortality in severe chronic heart failure N Engl J Med 1991, 325:1468-1475 1944425
5. Cowley AJ Skene AM Treatment of severe heart failure: Quantity or quality of life? A trial of enoximone. Enoximone Investigators Br Heart J 1994, 72:226-230 1025506 7946771 10.1136/hrt.72.3.226
6. Cohn JN Archibald DG Ziesche S Franciosa JA Harston WE Tristani FE Dunkman WB Jacobs W Francis GS Flohr KH Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study N Engl J Med 1986, 314:1547-1552 3520315
7. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 1992, 327:685-691 1463530
8. Berk JL Hagen JF Fried VJ The effect of vasopressin on oxygen availability Ann Surg 1979, 189:439-441 1397256 443898 10.1097/ 00000658-197904000-00009
9. Holmes CL Patel BM Russell JA Walley KR Physiology of vasopressin relevant to management of septic shock Chest 2001, 120:989-1002 10.1378/ chest.120.3.989 11555538
10. Dunser MW Mayr AJ Ulmer H Ritsch N Knotzer H Pajk W Luckner G Mutz NJ Hasibeder WR The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: A retrospective analysis Anesth Analg 2001, 93:7-13 10.1097/00000539-200107000-00003 11429329
11. Rona G Catecholamine cardiotoxicity J Mol Cell Cardiol 1985, 17:291-306 10.1016/S0022-2828(85)80130-9 3894676
12. Todd GL Baroldi G Pieper GM Clayton FC Eliot RS Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions J Mol Cell Cardiol 1985, 17:317-338 10.1016/S0022-2828(85)80132-2 3894677
13. Lee JC Downing SE Ventricular function in norepinephrine-induced cardiomyopathic rabbits Am J Physiol 1982, 242:H191-H196 7065151